| Trial Identifier: | D6015C00003 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02610075 |
| Start Date: | December 2015 |
| Primary Completion Date: | April 2018 |
| Study Completion Date: | April 2018 |
| Condition: | Cancer - Other; Ovarian Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation |
| Country | Location |
|---|---|
| United States of America, AZ | Scottsdale, AZ, United States of America, 85258 |
| United States of America, CO | Denver, CO, United States of America, 80218 |
| United States of America, TN | Nashville, TN, United States of America, 32705 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company